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Abstract 
The vertebrate gut symbiont Lactobacillus reuteri has diversified into separate clades 
reflecting host origin.  Strains show evidence of host adaptation, but how host-microbe co-
evolution influences microbial-derived effects on hosts is poorly understood. Emphasizing 
human-derived strains of L. reuteri, we combined comparative genomic analyses with functional 
assays to examine variations in host interaction among genetically distinct ecotypes. Within 
clade II or VI, the genomes of human-derived L. reuteri strains are highly conserved in gene 
content and at the nucleotide level. Nevertheless, they share only 70-90% of total gene content, 
indicating differences in functional capacity. Human-associated lineages are distinguished by 
genes related to bacteriophages, vitamin biosynthesis, antimicrobial production, and 
immunomodulation. Differential production of reuterin, histamine, and folate by 23 clade II and 
VI strains was demonstrated. These strains also differed with respect to their ability to modulate 
human cytokine production (TNF, MCP-1, IL-1, IL-5, IL-7, IL-12, and IL-13) by myeloid cells. 
Microarray analysis of representative clade II and clade VI strains revealed global regulation of 
genes within the reuterin, vitamin B12, folate, and arginine catabolism gene clusters by the AraC 
family transcriptional regulator, PocR. Thus, human-derived L. reuteri clade II and VI strains are 
genetically distinct and their differences affect their functional repertoires and probiotic features. 
These findings highlight the biological impact of microbe:host co-evolution and illustrate the 
functional significance of subspecies differences in the human microbiome. Consideration of 
host origin and functional differences at the subspecies level may have major impacts on 
probiotic strain selection and considerations of microbial ecology in mammalian species.  
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Introduction   
Lactobacillus reuteri are natural residents of mammalian and avian gastrointestinal (GI) 
tracts as well as the human urogenital tract and breast milk. L. reuteri exhibits strain-specific 
beneficial properties relevant to human health, making it a model organism for studying 
host:symbiont interactions as well as microbe:host co-evolution.  Comparative genomic studies 
of Lactobacillus species performed as part of the Human Microbiome Project highlighted 
significant heterogeneity within and between species and significant interspecies diversity among 
strains of L. reuteri (Nelson, et al. 2010). Previous phylogenetic studies of L. reuteri used 
amplified-fragment length polymorphism (AFLP) and multi-locus sequence analysis (MLSA) to 
study more than 100 strains, and these identified host origin as one basis for intraspecies 
diversity (Oh, et al. 2010), with lineage-specific genomic differences reflecting the niche 
characteristics in the GI tract of respective hosts (Frese, et al. 2011). Experiments in gnotobiotic 
mice supported host adaptation of L. reuteri strains, as only rodent strains colonized mice 
efficiently (Frese, et al. 2011). Human-derived L. reuteri strains belong to two distinct MLSA 
clades, designated clade II and VI.  Clade II is remarkably specific to humans and it clusters 
separately from all other clades, while human strains in clade VI are closely related to isolates 
from chickens (Oh, et al. 2010). Overall, the findings indicated that L. reuteri is a host-specific 
symbiont, and separate lineages within the species suggest that host restriction was maintained 
over evolutionary time spans, allowing host-driven diversification. The nature of evolutionary 
processes and their influence on specific host-microbe interactions and health status deserve 
exploration.   
The mutualistic relationship between L. reuteri and humans has been validated by 
numerous studies that have documented the ability of L. reuteri to elicit probiotic effects in 
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different disorders and disease models.  L. reuteri strains are acid and bile tolerant, produce 
many of the essential B complex vitamins, notably folate (B9) (Santos, et al. 2008b), and 
cobalamin (B12) (Morita, et al. 2008; Santos, et al. 2008a), but also potentially thiamin (B1) 
(Saulnier, et al. 2011) and riboflavin (B2) (Capozzi, et al. 2012).  Many strains synthesize the 
antimicrobial compound, reuterin (Axelsson, et al. 1989) and the organism synthesizes and 
secretes the anti-inflammatory biogenic amine, histamine (Thomas, et al. 2012).  Previous 
studies examining these probiotic properties and their regulation have indicated that not all 
strains of L. reuteri have equal capacity to express these factors or phenotypes (Jones and 
Versalovic 2009; Lin, et al. 2008; Spinler, et al. 2008).  
In this study, we compared the genomes of ten sequenced L. reuteri strains, derived from 
three host origins, to gain insight into the distinguishing features of human-derived L. reuteri 
strains, and to better understand the beneficial characteristics specific to human clades II and VI.  
We have complemented these genomic comparisons with functional data that classify the 
human-derived strains by gene expression, metabolic function, probiotic features, and effects on 
cytokine production by human immune cells. These data demonstrate clear differences between 
the two sub-populations of human-derived probiotic L. reuteri strains and emphasize the 
importance of performing studies on the role of the microbiome in an evolutionary context. 
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Methods 
Bacterial strains, human cell lines and culture conditions 
The human-derived L. reuteri strains and genome statistics are listed in Table 1. 
Additional strains used for functional assays are listed in Table 2.  Bacterial strains were 
routinely cultured in deMan, Rogosa, Sharpe medium (MRS; Difco, Franklin Lakes, NY) at 
37C in an anaerobic workstation (MACS MG-500, Microbiology International, Frederick, MD) 
supplied with a mixture of 10% CO2, 10% H2, and 80% N2 for 16-18 h.  Strains ATCC 
6475::pocR and DSM::pocR were cultured in the presence of erythromycin (10 g/mL).  Specific 
culture conditions for individual experiments are detailed throughout.  The effect of bacterial 
supernatants on cytokine production was performed with THP-1 cells (human monocytoid cell 
line, ATCC TIB-202, ATCC, Manassas, VA) maintained in RPMI (ATCC, Manassas, VA) and 
10% heat-inactivated fetal bovine serum (Invitrogen, Carlsbad, CA) at 37C with 5% CO2.  
Multi-Locus Sequence Analysis 
MLSA was performed on 119 L. reuteri strains.  This analysis was completed using 
standard techniques as previously described (Oh, et al. 2010).  In brief, seven housekeeping 
genes (D-alanine-D-alanine ligase (ddl), D-alanine-D-alanyl carrier protein ligase (dltA), DNA 
gyrase B subunit (gyrB), leucyl-tRNA synthetase (leuS), phosphoktolase (pkt), recombinase 
(recA) and RNA polymerase alpha subunit (rpoA)) were PCR amplified from all 119 L. reuteri 
strains, sequenced and included in the MLSA.  Clonal Frame software, 
http://bacteria.stats.ox.ac.uk (Didelot and Falush 2007), which uses a coalescent-based Bayesian 
method to infer strain relationships, was applied as described previously in Supplementary 
materials of Oh, et al. 2010 (Oh, et al. 2010).   
Lactobacillus reuteri genomes and pangenome analysis 
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Publicly available genome sequences for the ten L. reuteri strains (3 complete and 7 draft 
sequences) used in this study are described in Table 1. Three of the genomes (mlc3, lpuph and 
ATCC 53608) lacked annotations so the nucleotide sequences were submitted to the Integrated 
Microbial Genomes (IMG/ER) system (Markowitz, et al. 2010) for gene calling and feature 
prediction.  To maintain consistency, all annotation-based analyses were performed using the 
IMG annotations for the ten genomes.  For draft genomes, we used blastz within Advanced 
PipMaker (Schwartz, et al. 2000), to obtain ordered and oriented scaffolds or contigs for 
comparative analyses. The finished genome of JCM 1112 was used as the reference for clade II, 
ATCC 55730 for clade VI, 100-23 for mlc3 and lpuph, and I5007 (NC_021494) for ATCC 
53608. Once scaffolds or contigs were ordered and oriented, all were arranged so the genome 
sequence began with the start codon for the dnaA gene. These were the nucleotide sequences 
used for comparative analysis and alignments.  
Circular blastn-based representations of the ten L. reuteri genomes were constructed 
using BLAST Ring Image Generator (BRIG) (Alikhan, et al. 2011). For the incomplete 
genomes, ATCC 4659, CF48-3A, 100-23, mlc3, lpuph, and ATCC 53608, the ordered and 
oriented scaffolds were concatenated to create a single scaffold. These and the complete genome 
nucleotide sequences were used for input in the order shown in Figure 2 and Supplementary 
Figure S1, Supplementary Material online. The program passes the genomes to blastn (release 
2.2.28+) using default parameters with the first genome as the reference, and returns a graphical 
image of concentric rings where the density of color at a particular location within a ring 
indicates nucleotide homology with respect to the reference.  
A pangenome analysis was used to describe the L. reuteri species as a whole and to gain 
insight into the host-driven evolution of the species.  Genes in all 10 genomes were binned into 
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operational gene units using the online implementation of CD-HIT-EST (Huang, et al. 2010; Li 
and Godzik 2006) with default parameters (>90% nucleotide sequence identity spanning the 
length of the shorter gene in each pair-wise comparison) as described by Hansen, et al. (Hansen, 
et al. 2011).  The size of the core genome was estimated utilizing the distribution of shared 
OGUs among the ten genomes.  The function of each OGU was inferred from the annotations 
obtained from IMG. Higher level functions of were obtained from the Kyoto Encyclopedia of 
Genes and Genomes (KEGG) (Kanehisa, et al. 2012) and Cluster of Orthologous Genes (COG 
(Tatusov, et al. 2003)) assignments obtained from the IMG annotation files. 
Average nucleotide identity and gene conservation between genome pairs 
We compared the gene conservation at the nucleotide and amino acid levels across the L. 
reuteri genomes to assess diversity within the species.  Average nucleotide identity and gene 
conservation between the 10 L. reuteri genomes was calculated using the BLAST release 2.2.28+ 
(Altschul, et al. 1990), essentially as described previously (Konstantinidis and Tiedje 2005). For 
ANI, blastn was implemented using default parameters except with the drop-off value of 150 for 
gapped alignments (-xdrop_gap_final 150) and without query filtering/masking (-dust no). 
Average nucleotide identity was evaluated for all conserved genes having >60% sequence 
identity over >70% of the length of the query sequence. Gene content was computed using 
tblastn, where predicted protein-coding sequences from one L. reuteri genome (designated the 
query genome) were searched against the genomic sequence of a second L. reuteri genome 
(designated the reference genome), utilizing default settings plus the option –db_gencode 11. 
The tblastn output was filtered by top bit score and e-value per query, then the query hit was 
used to score conservation, defined as a CDS having >60% sequence identity over >70% of the 
length of the reference CDS.  
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Inactivation of pocR by insertional mutagenesis and comparative transcriptional analysis 
of ATCC 6475::pocR to DSM 17938::pocR 
The pocR gene was inactivated in DSM 17938 as previously described for strain ATCC 
6475 (Santos, et al. 2011).  Briefly, the internal fragment of the pocR gene was amplified by 
PCR using primers RB1883F2 5’BHI and RB1883R2 3’ERI (Supplementary Table S1, 
Supplementary Material online), and inserted into plasmid pORI28 (Russell and Klaenhammer 
2001) by directional cloning using standard techniques (Sambrook and Russell 2001) to generate 
pORIpocR.  Temperature-sensitive, site-specific integration of the non-replicating plasmid 
pORIpocR was carried out as described earlier (Russell and Klaenhammer 2001; Santos, et al. 
2011; Walter, et al. 2005).  The resulting insertion mutant was designated DSM 17938::pocR. 
Comparisons of the transcriptome of ATCC 6475::pocR and its parent strain were 
performed using two-color microarrays and published previously [GEO GSE22926 (Santos, et 
al. 2011)].  The transcriptome of the pocR mutant strain, DSM 17938::pocR, and its parent strain 
were compared using two-color microarrays as was that of ATCC 6475::pocR  (Santos, et al. 
2011).  In brief, oligonucleotides were designed and synthesized from a draft genome sequence 
of L. reuteri ATCC 55730 (Saulnier, et al. 2011).  For expression analysis, stationary phase 
mRNA was isolated from three biological replicates of the pocR mutant and parent strain 
cultured anaerobically in a semi-defined medium, LDMIII (Jones and Versalovic 2009), as 
described previously (Saulnier, et al. 2011).  Synthesis, labeling, hybridization, and dye-swap 
comparisons of cDNA were performed also as previously described (Saulnier, et al. 2011).  
Microarray platform information and data for the DSM 17938 strains are deposited at the NCBI 
Gene Expression Omnibus (GEO GSE54324; http://www.ncbi.nlm.nih.gov/geo/).  All image 
analysis, normalization, and statistical analysis for the DSM 17938 data was performed as before 
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(Santos, et al. 2011).  Microarray data from the previously published ATCC 6475 data set was 
compared to the DSM 17938 data set.  Only probes common to both arrays were compared. 
Production and quantification of reuterin produced from L. reuteri strains 
Isolation of reuterin from L. reuteri supernatants was done as previously described 
(Spinler, et al. 2008).  Briefly, cell pellets were collected at various time points from anaerobic 
cultures of L. reuteri and were washed in sodium phosphate buffer, resuspended to ~1.5 x 1010 
cells ml-1 in glycerol solution then incubated anaerobically at 37°C for 1 hr.  The reuterin-
containing solution was collected, filter sterilized and stored at 4°C until further analysis.  
Reuterin-containing solutions were analyzed colorimetrically by absorbance spectroscopy as 
done previously (Spinler, et al. 2008).  A standard curve was generated using 0-6 mM of HPLC 
quantified reuterin (Spinler, et al. 2008) produced by L. reuteri DSM 17938. 
Preparation of L. reuteri supernatants 
L. reuteri supernatants were prepared and analyzed for folate and histamine 
concentrations, and for cytokine bioassays from human monocytes.  Strains were cultured 
anaerobically for 24 h at 37C in MRS, and then inoculated into LDMIII at an OD600 of 0.1.  
LDMIII cultures were incubated anaerobically at 37C for 24 h, then supernatants were 
collected, filter sterilized using polyvinylidene fluoride membrane filters (0.22 μm pore size, 
Millipore, Bedford, MA) and stored at -20C before further processing. 
Folate detection from L. reuteri supernatants 
Supernatants of L. reuteri strains were prepared as outlined above and tested for the 
production of folate by electrochemiluminescence (Wilson, et al. 2005). Folate levels in the 
filter-sterilized supernatants were determined by a competitive immunoassay using direct 
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chemiluminescence. Samples were pretreated to release folate conjugates from any endogenous 
binding proteins in the sample then the free folate was assayed by competition for binding to an 
acridinium-folate-bound biotin-folate binding protein. Binding was detected using avidin 
conjugated paramagnetic particles in the solid phase. The inter- and intra-assay coefficients of 
variation of the assay were <10%. 
Histamine production by L. reuteri strains and PCR amplification of hdcP, hdcA, hdcB 
and hisRS2 genes  
Supernatants of L. reuteri strains were tested for the production of the biogenic amine, 
histamine.  Filter sterilized supernatants were serially diluted in phosphate buffered saline and 
tested using a histamine ELISA kit (cat# 409010, Neogen, Lansing, MI) as per the 
manufacturer’s instructions.  Concentrations of histamine were normalized against culture OD600 
values.  PCR amplification was used to confirm the presence or absence of key genes involved in 
histamine production by L. reuteri strains.  The sequence of hisRS2 was unique from hisRS1 as 
to permit discrimination.  Genomic DNA was isolated from L. reuteri using the MO BIO Ultra 
Clean Microbial gDNA isolation kit (Carlsbad, CA) as per manufacturer’s instructions.  Target 
genes were amplified by PCR using standard techniques (Sambrook and Russell 2001), using 
primers listed in Supplementary Table S1, Supplementary Material online. 
Bioassay of cytokine production from human monocytes 
L. reuteri cell-free supernatants were prepared as outlined above and tested for effects on 
cytokine production by THP-1 cells as previously described (Pena, et al. 2004). Supernatants 
were vacuum-dried, resuspended in RPMI medium, and normalized by volume to OD600 = 1.5.  
THP-1 cells (5x104 cells) were stimulated to produce TNF by the addition of 100 ng mL-1 
Pam3Cys-SKKKK x 3 HCl (EMC Microcollections, Tüebingen, Germany) as previously 
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described (Lin, et al. 2008; Pena, et al. 2004).  L. reuteri supernatants were added to the activated 
THP-1 cells (5% v/v) in microtiter plates, which were then incubated at 37°C in 5% CO2 for 3.5 
h. THP-1 cells were pelleted (3000 x g, 5 min, 4°C), and THP-1 supernatants were assayed using 
a Human Cytokine/Chemokine-Premixed 14-plex kit (Millipore, Billerica, MA) in a Luminex 
100 system (Luminex Corporation, Austin, TX).  The 14 analytes tested were: tumor necrosis 
factor (TNF), granulocyte macrophage colony-stimulating factor (GM-CSF), interferon (INF)-, 
interleukin (IL)-1, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12, IL-13, and monocyte 
chemoattractant protein (MCP)-1. Raw data were obtained with MasterPlex CT version 1.2.0.7 
and analyzed with MasterPlex QT version 5.0.0.73 (Hitachi MiraiBio, San Francisco, CA). 
Statistical analysis of microbiological data 
Statistical analyses were performed using SPSS 19.0 (IBM SPSS Statisticsm; 
http://www-01.ibm.com/software/analytics/spss/).  Data reported are means from a minimum of 
three biological replicates for reuterin, histamine, folate, and cytokine assays.  Conditions were 
defined as negative control, positive control, clade II, or clade VI.  A one way ANOVA analysis 
was run between conditions to generate p-values.  A Tukey HSD (Honestly Significant 
Difference) algorithm was applied to the ANOVA result to reduce the Type I error rate (false 
positives).  All significance values are based on p < 0.05.  Folate data were analyzed using the 
Student’s t-test with one-tailed distribution and considered statistically significant at a p-value ≤ 
0.05, unless otherwise stated. 
Results and Discussion 
General features of L. reuteri genomes  
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As of June 2013, the genomes of ten Lactobacillus reuteri strains had been sequenced (3 
complete genomes and 7 draft sequences), and their features are described in Table 1. Additional 
L. reuteri genomes of strains I5007 and TD1, were deposited in NCBI during the preparation of 
this manuscript, but were not included in this analysis.  The genomes of the strains analyzed here 
are similar in size (1.9 – 2.3 Mb), G+C content (38.4 – 39.0%), and contain between 1,820 – 
2,300 reported predicted protein-coding sequences.  The L. reuteri strains are isolates from three 
host types (human, rodent, and pig) and were collected from four geographically distinct regions 
within Australasia, Europe, North America, and South America.  L. reuteri is grouped into host-
associated clades based on MLSA typing (Figure 1, Table 1), and the ten genomes were assigned 
to clades I-IV and VI by Oh, et al. (Oh, et al. 2010), with six genomes from human-derived 
strains belonging to clades II and VI. To visualize differences between the genomes, we 
generated the nucleotide alignments of the genomes shown in Figure 2 by blastn using the 
complete clade II genome (JCM 1112) as the reference and the program BLAST Ring Generator 
(BRIG) (Alikhan, et al. 2011). We also created a clade VI reference alignment, using the 
completed genome of ATCC 55730 as the reference, which is shown in Supplementary Figure 
S1, Supplementary Material online.   
We conducted a pangenome analysis to better understand the distinct and independent 
evolution of the L. reuteri strains.  All predicted protein coding genes present in these genomes 
(~20,600 genes) were binned into “operational gene units” (OGUs) with other genes having  
>90% identity using the program CD-HIT (Huang, et al. 2010).  Based on this analysis, we 
predict that the L. reuteri pangenome encompasses approximately 3,700 genes.  The overall 
conserved genome is ~1.2 Mb, which represents about 1,230 core OGUs.  Strain-specific 
differences are defined by those genes, within the pangenome, which are not shared among 
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strains.  Although these genes are referred to as “unique”, this designation is context-dependent, 
and it is possible that they may be found in other bacterial species.  We have identified 1,200 
unique genes (OGUs) in L. reuteri, as well as ~1,320 dispensable genes, which are neither 
unique genes, nor members of the core genome.  The predicted pangenome contains 
approximately 3,700 OGUs, and the number of new OGUs accumulating within the pangenome 
began to plateau after the addition of eight L. reuteri genomes (~16,500 coding sequences), 
indicating its approach to saturation. The rate and shape of the rarefaction curve (data not shown) 
predicts that the pangenome should close with approximately 24 L. reuteri genomes.  
Examining ecological and evolutionary diversity within L. reuteri  
To explore patterns of evolution and ecology within L. reuteri, pair-wise genomic 
comparisons of the average nucleotide identity (ANI) of each predicted coding sequence (CDS) 
were compared to the amino acid similarity (gene content) of each CDS (Figure 3).  Higher 
percentage values of both ANI and gene content suggest genomes have evolved similarly and 
inhabit comparable niches, while lower percentage values indicate genomes that have evolved 
divergently and adapted to different environments (Konstantinidis, et al. 2006).  The ten-genome 
pair-wise comparison revealed two distinct populations within the L. reuteri species and 
confirmed similar intraspecies diversity revealed earlier with a seven-genome comparison 
reported by Nelson, et al. (Nelson, et al. 2010).  Despite having been isolated from disparate 
hosts, all clades shared ANI of 95% or greater.   Utilizing a bacterial species definition of 70% 
DNA-DNA hybridization (Wayne 1987) or ≥95% ANI (Konstantinidis and Tiedje 2005), the 
intraspecies divergence observed among our strains does not dictate a new species designation, 
since all pair-wise comparisons have ≥95% ANI (Figure 3A).  Of note, the two human-derived 
clades were as dissimilar to one another as they were to clades that contained rodent or porcine-
 at U
niversity of N
ebraka-Lincoln Libraries on June 20, 2014
http://gbe.oxfordjournals.org/
D
ow
nloaded from
 
 16 
 
derived strains, suggesting that the two human clades may have evolved separately.  Conversely, 
within-clade ANI values exceed 99% similarity and gene content levels of 92-100% suggesting 
that genomes within clades II and VI may have undergone clade-specific clonal diversification. 
The population structure and the distinct genomic features of L. reuteri lineages indicate 
that these lineages may have been shaped by different evolutionary forces, and we hypothesized 
that metabolic functions and probiotic phenotypes would differ among the two human-derived L. 
reuteri ecotypes.  Here we consider the definition of an ecotype to represent a cohesive group 
that possesses all the dynamic properties attributed to a species, but one that remains irreversibly 
separate and ecologically distinct (Cohan and Koeppel 2008). Our findings confirm extremely 
low sequence variation among strains within the same human ecotype.  By MLSA analysis, 
human-derived L. reuteri clade VI strains cluster closely with strains of poultry origin, while 
clade II strains almost exclusively associate with other human-derived strains (Figure 1).  
Additionally, our pangenome analysis showed that the majority of the genes that distinguished 
strains in clades II and VI encode hypothetical proteins (data not shown).  These observations are 
similar to those from Bacillus anthracis and Salmonella enterica pathovar Typhi genome 
projects, where strains were considered identical because of >99% ANI, but where further 
examination revealed the acquisition of a small number of genetic elements capable of 
delineating distinct ecotypes (Konstantinidis and Tiedje 2005). In this study, we made 
predictions of function based on genome content using genome sequences of six human-derived 
L. reuteri strains that represent clades II and VI (see Figure 2 and Supplementary Figure S1, 
Supplementary Material online). To validate the functional differences defining the two human-
derived ecotypes, we expanded our study to analyze the clade-specificity of probiotic-associated 
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traits of 25 human-derived L. reuteri strains representing clades II (twelve strains) and clade VI 
(thirteen strains) (Table 2; Figure 1). 
The presence of clade-specific mobile genetic elements support clonal evolution of 
human-derived L. reuteri strains 
Mobile genetic elements (such as insertion elements, transposons, and genes associated 
with bacteriophage) contribute to host specialization of L. reuteri (Frese, et al. 2011), and 
accounted for an additional 126 OGUs specific to human-derived strains.  Two complete 
prophages, unique to the clade II genomes are clearly identified in Figure 2.  We assigned new 
open reading frames (ORFs) and updated the annotations (Supplementary Tables S2a-S2b, 
Supplementary Material online) as described in the Materials and Methods.  Lreu1 is about 54 
kb in length and is 100% identical among the clade II genomes. It is inserted between a 
gluconate transporter and the riboflavin synthase alpha and beta subunits, and its structural 
proteins are most similar to other temperate Siphoviridae proteins from L. plantarum genomes. 
The second prophage, Lreu2, is about 43.5 kb long, also is 100% conserved and lies between 
the 50S large subunit protein gene rpsL and the beta-galactosidase operon. It contains a potential 
self-splicing intron element at its terminus. The Lreu2 structural proteins suggest that it may 
also be a member of the Siphoviridae, as its capsid, portal and head-tail joining proteins are very 
similar to those of phage HK97 family phages. The clade VI strains also contain two complete 
prophages (Lreu3 and Lreu4) that were revealed on the blastn-based map using ATCC 55730 
as the reference genome (Supplementary Figure S1, Supplementary Material online). The 
annotations for these, also likely Siphoviridae, are listed in Supplementary Tables S2c and S2d, 
Supplementary Material online. Many transposases are present in the genomes, though their 
types and distributions vary between clades II and VI.  Most notably, all of the sequenced clade 
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II genomes carry 19 copies of the IS200/IS605 family transposase gene while the clade VI 
genomes have only two.  This IS200/IS605 family of insertion elements is of interest because 
they are the smallest known, lack characteristic inverted repeats, and insert in a site-specific 
manner (Barabas, et al. 2008). The 100% identity and clade-specific delineation of 
bacteriophages and transposase genes in these genomes corroborate the notion that the human-
derived clade II and VI genomes are distinct clonal groups, and further support the idea that 
human-derived L. reuteri strains have undergone a clade-specific selective sweep important for 
adapting to the human gastrointestinal tract (Walter, et al. 2011). 
Distinct metabolic functions and probiotic phenotypes have evolved to define the two 
human-derived L. reuteri ecotypes.   
Probiotic L. reuteri produce factors that are beneficial to the mammalian host, aid in host 
defense, and help to maintain a homeostatic relationship in the gut. Many strains synthesize the 
antimicrobial compound, reuterin (Axelsson, et al. 1989), and specific strains synthesize and 
secrete the anti-inflammatory biogenic amine, histamine (Thomas, et al. 2012); each of which 
will be discussed in detail later.  Additionally, lactic acid bacteria create local acidic 
environments and synthesize essential B complex vitamins.  
L. reuteri has an arginine catabolism mechanism that may function to promote local 
acidic environments and facilitate survival at low pH (Marquis, et al. 1987). An approximately 
27 kb gene cluster, which is flanked by an IS200 insertion element and maps between 484,793 
and 511,393 in JCM 1112, carries core and dispensable genes that are observed in multiple 
clades but have a specific gene order and composition in clades II and VI (Figure 2); updated 
annotations for these are presented in Supplementary Table S3, Supplementary Material online.  
The region contains 31 ORFs and carries the arc genes responsible for producing enzymes that 
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catabolize arginine to citrulline and ornithine and ultimately to ammonia, thereby providing a 
means for L. reuteri to thrive in the presence of low pH in the lactic acid environment or during 
gut transit.  
L. reuteri produce many essential B complex vitamins (Capozzi, et al. 2012; Morita, et al. 
2008; Santos, et al. 2008a; Santos, et al. 2008b; Saulnier, et al. 2011). Folate (vitamin B9), 
specifically, is formed from the precursor molecules, 6-hydroxymethyl-7,8-dihydropterin 
pyrophosphate (DHPPP) and para-aminobenzoic acid (pABA).  Most lactobacilli encode the 
enzymes required to generate folate from DHPPP and pABA, but not those required for pABA 
synthesis (Rossi, et al. 2011); thus, they are not predicted to perform de novo synthesis of folate 
(Supplementary Figure S2, Supplementary Material online).  Unexpectedly, many of the clade 
VI L. reuteri strains tested do produce folate in the presence of limiting concentrations of pABA, 
while folate production by clade II strains was not observed under these conditions 
(Supplementary Figure S2, Supplementary Material online). The organization of the folate genes 
is similar in both clades, and the proteins have high sequence homology (93-99%).  The folB, 
folK, folE, thfs (folC2), folQ, and folP genes are clustered and map between nucleotides 
1,363,448 and 1,369,044 in JCM 1112 (Figure 2; Supplementary Table S4, Supplementary 
Material online); folA and folC1 are single genes that map at other positions within the genome 
(Supplementary Table S4, Supplementary Material online).  
Production of the antimicrobial compound, reuterin, is enhanced in L. reuteri clade VI 
strains   
Most human-derived isolates of L. reuteri produce the broad-spectrum antimicrobial 
compound, reuterin (a mixture of 3-hydroxypropionaldehyde isomers ) (Vollenweider, et al. 
2003; Walter, et al. 2011), from glycerol in a vitamin B12-dependent process (Axelsson, et al. 
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1989; Talarico and Dobrogosz 1990).  Reuterin production is dependent on the presence of the 
horizontally-acquired 57 gene cluster, pdu-cbi-hem-cob (Figure 4A; Supplementary Table S5, 
Supplementary Material online)(Morita, et al. 2008), which contains the pdu genes that encode 
enzymes required for glycerol and 1,2-propanediol utilization, linked to the cbi-hem-cob genes 
that encode the proteins required for the biosynthesis of vitamin B12, or cobalamin (Santos, et al. 
2008a).  In previous work, we observed that strain ATCC 55730 (clade VI) produced three-fold 
more reuterin than the clade II strains ATCC 6475, ATCC 4659, and ATCC 5679 during the 
stationary phase of growth (Spinler, et al. 2008). To further examine the strain-specific 
characteristics of reuterin production, we tested whether reuterin production by human-derived 
L. reuteri was growth phase dependent.   
We compared reuterin production in clade VI strain DSM 17938 (a plasmid-cured 
version of ATCC 55730 (Rosander, et al. 2008)) and ATCC 6475 (clade II), at time points 
representing logarithmic (4 h), early stationary (8 h), stationary (12 h), and late stationary (24 h) 
growth phases (Figure 4B).  In L. reuteri strain DSM 17938, reuterin production increased more 
than 16-fold from ca. 9 mM during logarithmic phase (4 h) to ca. 140 mM during stationary 
phase (12h, Figure 4B).  In contrast, in strain ATCC 6475, reuterin production was growth phase 
independent until late stationary phase and was about one third that of DSM 17938 (Figure 4B). 
To expand these observations, we measured in vitro reuterin production from stationary phase 
cultures of the 23 additional human-derived L. reuteri strains. Statistically significant (p< 0.05) 
clade-specific differences were observed with all but one clade VI strain (MM36-1a). With the 
exception of this strain, all clade VI strains produced >100 mM reuterin, while all but three of 
the clade II strains produced less than 50 mM reuterin (Figure 4C).   
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While the organization of the pdu-cbi-hem-cob gene cluster is conserved in all L. reuteri 
genomes that carry it, the genomic islands have distinct clade-specific sequence homology 
(Figure 2; Supplementary Figure S1, Supplementary Material online). A comparison of the 
amino acid identity of each predicted ORF from the human strains relative to the corresponding 
ORF in ATCC 55730 is shown in Figure 4A. Note that all of the CF48-3A protein sequences are 
100% identical to those of ATCC 55730.  In clade II, high levels of homology between clades 
(>95%) are restricted to two of the three reuterin biosynthesis proteins (PduC and PduD) plus 
additional proteins encoded by the pdu operon. The predicted vitamin B12 biosynthesis proteins 
encoded by the pdu-cbi-hem-cob genomic island are not as similar between clades (61-95% 
identity) (Figure 4A).  The glycerol dehydratase requires vitamin B12 as a cofactor for activity, so 
differences in vitamin B12 biosynthetic capacity should also impact the organism’s capacity to 
produce reuterin.   
Clade-specific transcriptional regulation by the AraC-like regulator, PocR 
Just as pathogenic microbes possess stringent mechanisms for regulating virulence 
factors, beneficial microbes have evolved specific mechanisms for regulating probiotic functions.  
A gene encoding one such regulator, PocR, which is a member of the AraC family of 
transcriptional regulators, is encoded by the pdu-cbi-hem-cob gene cluster (Morita, et al. 2008).  
The 364 amino acid PocR protein encoded by ATCC 55730 and CF48-3A is 100% identical, 
however the clade VI and clade II proteins are only 80% identical (Figure 4A). In a previous 
study comparing RNA expression levels from wild-type and a pocR insertion mutant in ATCC 
6475, we showed that PocR regulates transcription of operons involved in both reuterin and 
vitamin B12 synthesis in the clade II strains JCM 1112 and ATCC 6475 (Santos, et al. 2011).  
The growth phase dependent production of reuterin observed in clade VI strain DSM 17938 
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suggested that its production might be transcriptionally regulated. To test this, we created an 
equivalent pocR insertion mutant in DSM 17938 and performed comparative microarray 
analysis. Inactivation of pocR in either ATCC 6475 or DSM 17938 affected expression of genes 
within the pdu-cbi-hem-cob gene cluster as anticipated (Supplementary Figure S3 and 
Supplementary Tables S6 and S7, Supplementary Material online), but also affected the 
expression of genes at other loci relevant to probiosis, including genes involved in arginine 
catabolism and folate production, as listed in Supplementary Tables S6 and S7, Supplementary 
Material online.  Although not part of this study, it should be noted that we previously were able 
to complement the ATCC 6475::pocR mutation with a plasmid-borne copy of the ATCC 6475 
pocR gene (Santos, et al. 2011) so the insertions are likely non-polar. 
When comparing PocR-affected gene expression, the most striking strain-dependent 
difference was observed for pocR itself.  PocR is predicted to function by both activating and 
repressing transcription from cognate promoters (Santos, et al. 2011), and as an AraC family 
transcriptional regulator it may also regulate its own transcription. Because the pocR mutants 
were gene interruptions, not deletions, it was possible to score pocR transcription in the mutants. 
Under the conditions tested, DSM 17938 (clade VI) PocR did not affect its own expression, 
however in ATCC 6475, pocR transcription was repressed ~38 fold, suggesting that the protein is 
auto-regulatory in this clade II strain (Supplementary Figure S3 and Tables S6 and S7, 
Supplementary Material online).  These results, along with others (Chen, et al. 1994; Mellin, et 
al. 2013; Rondon and Escalante-Semerena 1992; Santos 2008), indicate that strain-specific 
regulatory mechanisms can exist within human-derived L. reuteri  
Strain-dependent transcriptional regulation by PocR is observed for the major regulons of 
the 57 gene pdu-cbi-hem-cob cluster (Supplementary Figure S3, Supplementary Material online).  
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As discussed, the pdu genes encode distinct functions including the production of the 
antimicrobial compound, reuterin (Morita, et al. 2008; Talarico and Dobrogosz 1990) and the 
utilization of glycerol and propanediol as electron acceptors to support growth (Sriramulu, et al. 
2008; Talarico, et al. 1990).  This is in contrast to other organisms that have two isofunctional 
vitamin B12-dependent enzymes for dehydrating glycerol or propanediol (Daniel, et al. 1998; 
Toraya and Fukui 1977; Toraya, et al. 1980). Since the PduCDE enzyme is vitamin B12 
dependent, upregulation of the cbi-hem-cob genes along with the pdu genes, as observed in strain 
DSM 17938 (clade VI), is consistent with elevated reuterin production by this clade (Figure 4). 
Conversely, the low level of expression of cbi-hem-cob genes in ATCC 6475, even in the 
presence of high levels of pdu expression, may explain the reduced reuterin production in this 
clade (Supplementary Figure S3, Supplementary Material online). Overall, these data suggest 
that the human-derived strains from clade II and VI differentially exploit the functionality of the 
pdu-cbi-hem-cob cluster, with the former focusing this cluster on energy gain while the latter 
produce more reuterin.   
Factors produced by L. reuteri strains differentially affect cytokine production by human 
myeloid cells 
We quantified eleven human cytokines produced by stimulated THP-1 monocytoid cells 
in response to treatment with cell-free supernatants from twelve clade II and thirteen clade VI 
strains (Figure 5).  The effects were generally clade-specific and consistent with the prior 
literature regarding L. reuteri and immunomodulation (Pena, et al. 2005). Clade II strains can be 
considered anti-inflammatory based on aggregate cytokine responses (Figure 5) and the 
established correlation between TNF inhibition and suppression of intestinal inflammation by L. 
reuteri (Hemarajata, et al. 2013; Pena, et al. 2005).  In addition to suppressing TNF, most clade 
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II strains suppressed monocyte chemoattractant protein-1 (MCP-1), IL-1β, and interleukin-12 
(IL-12).    Suppression of the pro-inflammatory cytokines TNFCP-1, IL-1β, and IL-12 by 
clade II strains is consistent with the known ability of L. reuteri strain ATCC 6475 to suppress 
intestinal inflammation.  
In contrast to the suppression of pro-inflammatory cytokines by clade II, supernatants 
derived from clade VI strains stimulated IL-7, IL-12, and IL-13 production (p < 0.05 versus 
media control and clade II strains, Figure 5).  Clade VI strains are considered immunostimulatory 
based on these aggregate cytokine responses and they may serve the host by promoting the 
development and maintenance of an active mucosal immune surveillance system.  Most clade VI 
members (but not ATCC 55730 and CF48-3A) suppressed IL-5 production (Figure 5); these 
findings appear to be inconsistent with the aggregate cytokine responses. However, IL-5 can play 
a prominent role at sites distal to the intestine and may modulate immune responses at other body 
sites. IL-5 is a cytokine that promotes eosinophil differentiation from bone marrow precursor 
cells, and acts as a potent eosinophil chemoattractant (Akuthota and Weller 2012). Eosinophilic 
inflammation contributes to distinct disease phenotypes of the skin, lungs, and sinuses, and 
suppression of eosinophilic inflammation could be beneficial in decreasing atopic and allergic 
diseases away from the intestine. Oral administration of L. reuteri ATCC 55730 (clade VI) can 
modulate IFN- and IL-4 cytokine expression at sites distal from the intestine in patients with 
atopic dermatitis (Miniello, et al. 2010), and can reduce the incidence of IgE-associated eczema 
at 2 years of age (Abrahamsson, et al. 2007; Forsberg, et al. 2013).  Others have shown that oral 
administration of L. reuteri modulates allergic airway responses in mice (Forsythe, et al. 2007; 
Karimi, et al. 2009).  
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Histamine production by L. reuteri clade II strains corresponds with anti-inflammatory 
properties.   
The anti-inflammatory properties of L. reuteri ATCC 6475 (clade II) have been 
extensively characterized, and some have recently been linked to its ability to produce histamine 
from histidine (Hemarajata, et al. 2013; Thomas, et al. 2012).  In L. reuteri, and other 
lactobacilli, histamine is produced by a pyruvoyl-dependent histidine decarboxylase (HdcA) 
(Thomas, et al. 2012). The hdcA gene is linked to hdcB, encoding a protein of unknown function 
that is presumed, by association, to have a role in the decarboxylation system (Le Jeune, et al. 
1995; van Poelje and Snell 1990). A gene encoding a histidine-histamine antiporter (hdcP) 
(Lucas, et al. 2005) lies immediately upstream of hdcAB in the clade II strains and they are 
directly linked to a second histidyl-tRNA synthetase (hisRS2) gene that shares limited homology 
with the core hisRS gene (Figure 6A). The predicted HisRS2 protein contains the catalytic 
residues required for histidyl-tRNA synthesis (Sissler, et al. 1999) so it is likely that this protein 
contributes to the pool of charged tRNAs available for protein synthesis under conditions of 
histidine depletion in this organism, which is a histidine auxotroph.  
In JCM 1112, the histidine decarboxylase locus maps between coordinates 1923821 and 
1928862 (Supplementary Table S8, Supplementary Material online) and it occurs at similar 
chromosomal positions in the genomes of DSM 20016, ATCC 4659, and ATCC 6475, but the 
genes are not present in the genomes of ATCC 55730 or CF48-3A. PCR analysis of additional 
nonsequenced clade VI strains revealed the occasional presence of the gene cluster in this clade 
(see below). Database searches revealed the presence of complete histidine decarboxylase gene 
clusters on Lactobacillus plasmids pLRI01 (GenBank NC_021504), pLF01 (GenBank 
AVAB01000110), and an unstable 80 kb plasmid in L. hilgardii IOEB 0006 (Lucas, et al. 2005); 
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as well as in several Lactobacillus genomes: L. buchneri B301 (Martin, et al. 2005), L. 
saerimneri 30a (Romano, et al. 2013), L. sakei LTH 2076 (GenBank DQ13288) and L. vaginalis 
ATCC 49540 (GenBank NZ_ACGV0). The histidine decarboxylase gene (hdcA) is also found in 
the incomplete genomes of L. fructivorans KCTC 3543 (GenBank NZ_AEQY) and L. rossiae 
DSM 15814 (GenBank NZ_AUAW). 
Bioassays of the 25 human-derived L. reuteri strains show that the majority of clade II 
strains produced histamine (Figure 6B), and conditioned media from histamine producers 
suppressed TNF production from human monocytes by more than 50% relative to controls 
(Figure 5).  All L. reuteri strains, including those in clade VI, were tested by PCR for the 
presence of the hdcP, hdcA, hdcB, and hisRS2 genes (Figure 6B). As expected, all histamine 
producing strains in both clades contained the entire gene cluster and non-producing strains 
lacked the histidine decarboxylase gene and hdcB. Clade II strains SR-11 and SR-14 were 
hdcP+hdcA-hdcB-hisRS2+ suggesting that they may have incurred an internal deletion within the 
gene cluster; the presence of this deletion was not confirmed.   Clade VI strains M81R43 and 
MV36-2a both yielded a positive signal for the hisRS2 gene but were negative for the remainder 
of the histidine decarboxylase gene cluster. Two clade VI strains, M45R2 and MM36-1a, are 
hdcP+hdcA+hdcB+hisRS2+ and produce histamine (Figure 6B), but do not suppress TNF 
production (Figure 5).  Perhaps these strains produce histamine antagonists or other factors that 
counteract this anti-inflammatory phenotype.  While histamine production by L. reuteri clade II 
strains has clearly been linked to the TNF-suppressive phenotype, other clade specific factors 
may be responsible for the effects on additional anti-inflammatory cytokines observed here. 
Do distinct probiotic functions reflect the evolutionary history of strains? 
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Our analyses demonstrate that strains of clade II and VI differ substantially in their 
functional attributes, which is likely to reflect their distinct ecology and the symbiotic 
relationships that they maintain with their hosts.  Currently, we can only speculate on how these 
differences evolved.  The majority of clade II isolates were isolated from human fecal samples, 
and these strains do not cluster with isolates from other host species (Oh et al., 2000), suggesting 
that clade II represents the autochthonous L. reuteri population in the human intestinal tract. In 
contrast, in clade VI, human isolates cluster tightly with isolates from poultry (Oh et al., 2010), 
and since strains from this cluster are extremely rare in human fecal samples (but very common 
in poultry fecal samples), they might be allochthonous to humans originating from poultry 
(Frese, et al. 2011; Oh, et al. 2010).  Alternatively, if we consider that the majority of human-
derived clade VI strains are indeed autochthonous to humans, the population genetic structure 
suggests that migration to humans was very recent. In either case, it is likely that clade VI strains 
have evolved with poultry for most of their evolutionary history.  Our findings support such 
distinct evolutionary trajectories. 
The ecological niches occupied by L. reuteri strains in the GI tracts of chickens and 
humans are highly distinct.  L. reuteri is one of the most abundant Lactobacillus spp. in the crop 
of chickens where it forms biofilms on the stratified squamous epithelium of the crop (Abbas 
Hilmi, et al. 2007).  Accordingly, genome comparisons by microarray analysis revealed that 
genome content of clade VI strains is more similar to rodent and pig strains, reflecting 
similarities in lifestyle, probably related to similarities in biofilm formation in the proximal 
gastrointestinal tract of these animals.  In contrast, the human gastrointestinal tracts do not 
contain stratified squamous epithelia, and Lactobacillus biofilms have not been demonstrated in 
the human gut (Walter 2008).  This is consistent with the genome content of clade II strains, 
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which have deleted virtually all large surface proteins annotated as adhesins and the two EPS 
clusters present in L. reuteri strains from rodents (Frese et al., 2011).   
Following the theory that clade II strains are autochthonous to humans, they might focus 
the function of the PduCDE enzyme on propanediol utilization and energy generation to support 
growth in the human gut where simple sugars are limited.  Propanediol is produced by gut 
microbes as a fermentation byproduct of rhamnose and fucose (Badia, et al. 1985).  These simple 
sugars are components of glycoconjugates found in intestinal epithelial cells and plant cell walls 
(Bry, et al. 1996), as well as in breast milk oligosaccharides (Castanys-Munoz, et al. 2013).  
Sriramulu, et al. (Sriramulu, et al. 2008) have shown that DSM 20016 (clade II) shows a growth 
advantage over rodent-derived L. reuteri 100-23 (that lacks the pdu-cbi-hem-cob cluster) when 
propanediol is provided in the growth medium, further supporting the idea that clade II strains 
preferentially utilize the propanediol dehydratase activity of PduCDE. 
Furthermore, the cytokine bioassays reveal that most clade II strains are associated with 
suppression of pro-inflammatory cytokines produced by macrophages, while most clade VI 
strains are associated with a general pro-inflammatory cytokine increase, and specifically 
suppress IL-5.  Clade VI strains may play an important role in fostering development and 
maintenance of robust and fully mature immune responses by the gut microbiome. Clade II 
strains may serve an equally important role in helping the host regulate and resolve immune 
responses, and suppress potentially deleterious effects of mucosal inflammation.  Since the 
immune cells used in our assays are of human origin, the findings might reflect the distinct 
relationships of the clades with the human host. 
Conclusions 
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Host-driven evolution of L. reuteri has resulted in ecotypes that specialize towards 
particular host species (Frese, et al. 2011; Oh, et al. 2010). We show that human strains from two 
distinct ecotypes differ markedly in bacterial functions that are likely to influence the 
interrelationships of these strains with the human host (Figure 7), indicating that the evolutionary 
trajectory of a gut microbe influences bacterial traits that can be beneficial to its host. The most 
striking differences between the two ecotypes are the amounts of the antimicrobial compound 
reuterin produced, and the remarkable differences in intestinal immunomodulatory capacity 
between the clades. Clade II strains can be considered immunosuppressive and clade VI strains 
can be considered immunostimulatory. The contrasting immunomodulatory effects of these two 
separate clades provide a prominent example how different lineages within a single bacterial 
species can benefit the host by different mechanisms. The different genomic characteristics of 
clades II and VI evident in the ANI and gene content analysis (Figure 3B) indicate that the 
evolution of the two human-derived L. reuteri ecotypes was influenced by separate and distinct 
environmental pressures (and potentially by two different hosts).  Most importantly, the 
evolutionary process impacted how strains interact with host cells. Thus, our work provides 
novel information about host-microbe interrelationships as it shows that distinct evolutionary 
paths within the same species are likely to determine how gut microbes impact their host, which 
is likely important for their health effects. Important lineage distinctions within a single bacterial 
species have recently been described in other organisms and include the distinction of two 
different clades of Wolbachia infecting the same population of Drosophila (Ellegaard, et al. 
2013), subclades of freshwater isolates of the Alphaproteobacteria SAR11 that are unique and 
distinct from saltwater clades (Zaremba-Niedzwiedzka, et al. 2013), and the identification of four 
distinct clades of Chlamydia trachomatis associated with four distinct disease types (Joseph, et 
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al. 2012).  These and our work are concrete examples of the evolution of discreet ecotypes within 
a bacterial species and address the “bacterial species concept” (Rossello-Mora and Amann 
2001).  These findings suggest that evolutionary criteria could be helpful for the selection of 
probiotic strains. Understanding the genomic basis of the probiotic characteristics associated 
with distinct lineages of L. reuteri will ultimately allow us to predict and assign groups of 
probiotic L. reuteri strains best suited to prevent or treat various classes of diseases.     
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Figures 
Fig. 1.  Phylogenetic analysis of L. reuteri isolates derived from four hosts.   
The genealogy of 119 L. reuteri strains based on analysis of MLSA sequences.  Tree branches 
are color coded by host origin: green = rodent, red = pig, blue = human, yellow = poultry.  The 
25 strains included in the functional analyses are indicated by closed black circles ( ), and 
strains with sequenced genomes are indicated by a closed black circle with a yellow center ( ).  
Reuterin production is designated as follows:   high reuterin production,  low reuterin 
production.  Strains that produce high amounts of folate are indicated by closed green circles ( ), 
and strains producing histamine are indicated by closed red circles ( ). 
Fig. 2.  Genomic comparison of ten L. reuteri genomes to clade II strain JCM 1112.  
Circular representation of ten L. reuteri genomes based on nucleotide homology with respect to 
JCM 1112. Diagram represents blastn results of each genome against JCM 1112 with results 
rendered using the BRIG program (Alikhan, et al. 2011). Each genome is color coded as 
indicated by the legend. Relative shading density (from darker to lighter) within each circle 
represents relative levels of nucleotide homology. White regions indicate regions with no 
identity to the reference. Features of interest are annotated. 
Fig. 3.  Ecological and genetic diversity within the L. reuteri species.  
Conserved genes (y-axis) versus average nucleotide evolutionary distance (x-axis) plot for ten 
sequenced L. reuteri genomes isolated from 3 mammalian hosts.  Each data point represents a 
whole-genome comparison between two genomes. A) Pair-wise comparisons between all ten 
genomes. Intra-clade comparisons of human-derived strains are circled near the origin. B) Pair-
wise comparisons of human-derived MLSA II and MLSA VI L. reuteri genomes.  
Fig. 4.  The pdu-cbi-hem-cob gene cluster and clade-specific reuterin production.   
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A) CDS map of the 57 gene pdu-cbi-hem-cob cluster that encodes the PocR regulator (shown in 
red), genes pduCDE responsible for production of the antimicrobial reuterin, Pdu proteins 
required for 1,2 propanediol and glycerol utilization, and Cbi, Hem and Cob proteins required for 
synthesis of vitamin B12, as per Morita, et al. (Morita, et al. 2008). Below the CDS map are heat 
maps representing percent amino acid identities of each protein within the pdu-cbi-hem-cob gene 
cluster of four MLSA II L. reuteri genomes relative to the amino acid sequences of MLSA VI 
proteins from strains ATCC 55730 and CF48-3A.  B) Growth curve of strains ATCC 6475 (clade 
II) and DSM 17938 (clade VI) in MRS medium at 37°C under anaerobic conditions (left); 
growth phase production of reuterin by strain ATCC 6475 (clade II) and DSM 17938 (clade VI) 
(right). C) Reuterin production at stationary phase (12h) from 25 human-derived L. reuteri 
strains.  Strains with sequenced genomes are indicated in bold with an asterisk (*). Results are 
expressed as the mean  SD, n=3, and significant differences between group means as 
determined by one-way ANOVA (p <0.05) are indicated by the placement of different letters 
above each bracketed group. 
Fig. 5.  The effects of L. reuteri secreted factors on cytokine profiles of human immune 
cells. 
Inflammatory cytokine production by TLR2-activated THP-1 cells in the presence of culture 
supernatants from L. reuteri clade II or clade VI strains.  Supernatants from THP-1 cells were 
assayed using a Human Cytokine/Chemokine-Premixed 14-plex kit in a Luminex 100 system. 
All values are presented on a 0 to 1 scale, indicating a max/min normalization per analyte and are 
displayed as heatmaps with red indicating values closer to the maximum (1) and green indicating 
values closer to minimum (0). 
Fig. 6.  Relative production of histamine by human-derived L. reuteri clades. 
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A) CDS map of the hdcP-hdcA-hdcB-hisRS2 gene cluster in clade II L. reuteri strains.  B) 
Histamine in conditioned media by 25 human-derived L. reuteri strains was measured by ELISA 
and compared to media control.  Results of end point PCR tests for the four histidine 
decarboxylase cluster genes are summarized: √ indicates correct PCR product observed; - 
indicates no PCR product observed. All values are presented on a 0 to 1 scale, indicating a 
max/min normalization per analyte and are displayed as heatmaps with red indicating values 
closer to the maximum (1) and green indicating values closer to minimum (0). 
Fig. 7.  Functional illustration of human-derived L. reuteri ecotypes. 
L. reuteri strains from both clades promote acidic environments, produce the antimicrobial 
reuterin, synthesize essential vitamins, and generate immunomodulatory compounds that effect 
immune signaling in the host.  The differences associated with each ecotype are illustrated here.   
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Tables  
Table 1.  Characteristics of sequenced L. reuteri strains.  
Strain Name 
(Alternate) 
MLSA Cladea Host 
(Body Site) 
Genome 
Length (bp) 
ORFs Scaffolds GenBank 
Accession Number(s) 
JCM 1112 II Human  
(GI Tract) 
2,039,414 1820 1 NC_010609 
DSM 20016 
(F275) 
II Human  
(GI Tract) 
1,999,618 1900 1 NC_009513 
ATCC PTA 4659 
(MM2-3) 
II Human 
(Breast Milk) 
1,943,466 2044 95 NZ_GG693756-6850 
ATCC PTA 6475 
(MM4-1A) 
II Human 
(Breast Milk) 
2,067,914 2095 7 NZ_ACGX02000001-007 
ATCC 55730 
(SD2112) 
VI Human 
(Breast Milk) 
2,264,399 2246 1 NC_015697 
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CF48-3A VI Human 
(GI Tract) 
2,032,595 2164 92 NZ_GG693664-755 
100-23 III Rat 
(GI Tract) 
2,305,557 2181 2 NZ_AAPZ02000001-002 
mlc3 III Mouse 
(GI Tract) 
2,018,630 1986 126b AEAW00000000 
lpuph I Mouse 
(GI Tract) 
2,116,621 2066 127b AEAX00000000 
ATCC 53608 
(1063) 
IV Pig 
(GI Tract) 
1,968,532 1864 13 NZ_FR854361-373 
  
aAs determined by Oh, et al. (Oh, et al. 2010)  
bNumber of contigs  
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Table 2.  Human-derived L. reuteri strains used in this study.  
Strain Name   
(Alternate) 
MLSA 
Cladea 
Isolation Site Source 
DSM 20016 II Feces DSMZb
ATCC PTA 4659 
(MM2-3) 
II Breast Milk BioGaia AB 
ATCC PTA 5289 
(FJ1) 
II Oral Cavity BioGaia AB 
ATCC PTA 6475 
(MM4-1A) 
II Breast Milk BioGaia AB 
CF15-6 II Feces BioGaia AB 
CF4-6g II Feces BioGaia AB 
JCM 1112 II Feces JCMc
LMS11-1 II Feces MGHd 
LMS11-3 II Feces MGH 
MM3-1a II Breast Milk BioGaia AB 
SR-11 II Stomach O’Toole, PW 
SR-14 II Stomach O’Toole, PW 
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ATCC 55730 
(SD2112) 
VI Breast Milk BioGaia AB 
CF48-3A VI Feces BioGaia AB 
CF6-2a VI Feces BioGaia AB 
DSM 17938 VI Breast Milk BioGaia AB 
M27U15 VI Breast Milk BioGaia AB 
M45R2 VI Breast Milk BioGaia AB 
M81R43 VI Breast Milk BioGaia AB 
MF14-C VI Feces BioGaia AB 
MF2-3 VI Feces BioGaia AB 
MM34-4a VI Breast Milk BioGaia AB 
MM36-1a VI Breast Milk BioGaia AB 
MV36-2a VI Vagina BioGaia AB 
MV4-1a VI Vagina BioGaia AB 
ATCC 6475::pocR II Breast Milk (Santos, et al. 2011) 
DSM 17938::pocR VI Breast Milk This study 
  
aAs determined by Oh, et al. (Oh, et al. 2010)  
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bDeutsche Sammlung von Mikroorganismen und Zellkulturen  
cJapan Collection of Microorganisms  
dMicrobiology Laboratories, Massachusetts General Hospital  
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Supplementary Material  
Supplementary figures S1-S3 and tables S1-S8 are available at Genome Biology and Evolution  
online (http://www.gbe.oxfordjournals.org/).    
Supplementary Table S1.  Primers used in this study.  
Supplementary Tables S2a – S2d.  Prophage Lreu1 - Lreu4 Gene Annotations.  
Supplementary Table S3.  Arginine Catabolism Gene Cluster Annotations.  
Supplementary Table S4.  Folate Biosynthesis Gene Annotations.  
Supplementary Table S5a-S5b.  The pdu-cbi-hem-cob Gene Cluster Annotations.  
Supplementary Table S6.  Microarray expression data for selected genes in clade II strain  
L. reuteri ATCC 6475 wild-type versus PocR mutant.  
Supplementary Table S7.  Microarray expression data for selected genes in clade VI  
strain L. reuteri DSM17938 wild-type versus PocR mutant.  
Supplementary Table S8.  Histidine Decarboxylase Gene Cluster for L. reuteri Clade II.  
Supplementary Fig. S1.  Genomic comparison of ten L. reuteri genomes to strain ATCC  
55730.  
Circular representation of ten L. reuteri genomes based on nucleotide homology with respect to  
ATCC 55730. Diagram represents blastn results of each genome against ATCC 55730 with  
results rendered using the BRIG program (Alikhan, et al. 2011). Each genome is color coded as  
indicated by the legend. Relative shading density (from darker to lighter) within each circle  
represents relative levels of nucleotide homology. White regions indicate regions with no  
identity to the reference. Features of interest are annotated.  
Supplementary Fig. S2.  Folate production by human-derived L. reuteri clades.   
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A) Schematic overview of para-aminobenzoic acid (pABA)-dependent dihydrofolate (DHF) and 
tetrahydrofolate (THF) biosynthesis by L. reuteri. Precursor 6-hydroxymethyl-7,9-dihydropterin 
pyrophosphate (DHPPP) is synthesized from GTP through the action of FolE, FolQ, FolB, and 
FolK, and then is condensed with externally acquired pABA by FolP to form DHP (7,8-
dihydropteroate), which is glutamylated via FolC1 to produce DHF (dihydrofolate). DHF can be 
further glutamylated to form DHF polyglutamate or can be converted to THF via ThfS (FolC2) 
and to THF polyglutamate by FolC1. B) Folate production in filtered supernatants of human-
derived clade II or VI L. reuteri strains cultured in a defined medium. The results are expressed 
as the mean  SD, n=3, * p <0.05 relative to medium control. Group means of clade VI assays 
were significantly different than those clade II group means and when compared to control 
medium alone.  Strains with sequenced genomes are indicated in bold with an asterisk (*). 
Supplementary Fig. S3.  Heatmap of PocR-regulated genes in the pdu-cbi-hem-cob gene 
cluster from ATCC 6475 and DSM 17938. 
CDS map of the 57 gene pdu-cbi-hem-cob cluster that encodes the PocR regulator (shown in 
red), genes pduCDE responsible for production of the antimicrobial reuterin, Pdu proteins 
required for 1,2 propanediol and glycerol utilization, and Cbi, Hem and Cob proteins required for 
synthesis of vitamin B12, as per Morita, et al. (Morita, et al. 2008). Below the CDS map are heat 
maps representing fold changes (>1.5) of the wild-type strain with respect to the isogenic pocR 
mutant strain (WT/pocR mutant) with an adjusted p-value < 0.05. Values having a p-value > 0.05 
are indicated as NS. Data for three genes was undetectable (ND). 
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       Supplementary Table S1. Primers used in this study.  
Primer Name Sequence (5’-3’) Target Gene Reference 
RB1883F2 5’BHI TGACGGATCCTAAGTGTGACTGGCACTGTTGTAGATTGTAATACGC pocR (DSM 17938) This Study 
RB1883R2 3’ERI TGACGATTCGTCAACATCAATATGTGAGGCATCAAG pocR (DSM 17938) This Study 
hdcP F3 TGGACATTGTGCATATTCCTATTCC hdcP This Study 
hdcP R GCGCTTCCTATTCCTTACAATCC hdcP This Study 
hdcA F GGATTGTAAGGAATAGGAAGCGC hdcA This Study 
hdcA R GCTCCACATCCACCTACCTTA hdcA This Study 
hdcB F GCTGTTTGTGTACCACGATGTA hdcB This Study 
hdcB R CCTAAGGTAAAGTGTTCCACCG hdcB This Study 
hisS F ATTTCGTGATGGGGAGCGTT hisS2 This Study 
hisS R TGCGGATAATTGAAGCCCATTA hisS2 This Study 
 
 
Supplementary Table S2a. Prophage Lreu1 Gene Annotationsa  
New Annotation Coordinates 
Gene Start Gene Stop Strand 
Protein  
(aa) 
Protein Function Prediction 
878463 879728 - 421 integrase/recombinase 
880043 880195 + 50 transposase 
880196 881053 - 285 hypothetical protein 
881074 881595 - 173 hypothetical protein 
881609 882013 - 134 conserved hypothetical Lactobacillus phage protein 
882067 882471 - 134 conserved hypothetical protein 
882488 882823 - 111 transcriptional regulator/phage repressor 
882984 883199 + 71 transcriptional regulator/phage repressor 
883218 883991 + 257 phage antirepressor 
884003 884131 + 42 hypothetical protein 
884131 884253 + 40 hypothetical protein 
884267 884470 + 67 hypothetical protein 
884467 884715 + 82 possible transcriptional regulator 
884693 884896 + 67 hypothetical protein 
884911 885087 + 58 hypothetical protein 
885087 885359 + 90 transcriptional regulator 
885352 886281 + 309 RecT family recombinase 
886265 887089 + 274 conserved hypothetical protein 
887094 887951 + 285 phage replication protein 
887944 888273 + 109 hypothetical protein 
888270 888641 + 123 hypothetical protein 
888638 888730 + 30 hypothetical protein 
888717 888995 + 92 hypothetical protein 
888992 889180 + 62 hypothetical protein 
889180 889332 + 50 hypothetical protein 
889376 889570 + 64 hypothetical protein 
889570 889830 + 86 hypothetical protein 
889830 890171 + 113 hypothetical protein 
890171 890359 + 62 hypothetical protein 
890367 890627 + 86 hypothetical protein 
890627 890938 + 103 hypothetical protein 
891001 891144 + 47 hypothetical protein 
891226 891648 + 140 possible phage recombinase/resolvase 
891661 891945 + 94 conserved hypothetical protein 
892596 892802 + 68 hypothetical protein 
892890 893558 + 222 conserved hypothetical protein 
893558 893983 + 141 conserved hypothetical protein 
893997 894776 + 259 possible ParB family nuclease 
894793 895296 + 167 hypothetical protein 
895271 896566 + 431 phage terminase, large subunit 
896566 898227 + 553 phage portal protein 
898227 899177 + 316 phage head morphogenesis protein 
New Annotation Coordinates 
Gene Start Gene Stop Strand 
Protein  
(aa) 
Protein Function Prediction 
899188 899433 + 81 hypothetical protein 
899563 900216 + 217 phage scaffold protein 
900231 901307 + 358 phage capsid protein 
901320 901685 + 121 conserved hypothetical Lactobacillus phage protein 
901685 901999 + 104 conserved hypothetical Lactobacillus phage protein 
901989 902549 + 186 phage head-tail joining protein 
902558 902968 + 136 conserved hypothetical Lactobacillus phage protein 
902971 903618 + 215 phage tail protein 
903638 904183 + 181 conserved hypothetical Lactobacillus phage protein 
904276 904455 + 59 hypothetical protein 
904459 908109 + 1216 phage tail tape measure protein 
908106 908993 + 295 conserved hypothetical phage protein 
908990 911221 + 743 M23 family peptidase/possible phage lysin 
911205 914786 + 1193 conserved hypothetical protein 
914779 915051 + 90 hypothetical protein 
915097 915366 + 89 conserved hypothetical Lactobacillus phage protein 
915379 916524 + 381 probable lipase 
916527 917636 + 369 conserved hypothetical Lactobacillus phage protein 
917648 918052 + 134 hypothetical protein 
918045 918164 + 39 hypothetical protein 
918203 918754 + 183 hypothetical protein 
918793 919962 + 389 hypothetical protein 
919977 920426 + 149 phage holin protein 
920416 921615 + 399 N-acetylmuramoyl-L-alanine amidase 
921687 921854 - 55 conserved hypothetical protein 
921867 923396 - 509 glucokinase 
923624 924157 + 177 GNAT family acetyltransferase 
924421 924525 - 34 hypothetical protein 
924665 924874 - 69 Lactobacillus conserved hypothetical protein 
925668 927581 + 637 amidase 
927663 927938 + 91 Lactobacillus conserved hypothetical protein 
927999 928490 - 163 conserved hypothetical Lactobacillus phage protein 
928800 930332 + 510 
type I restriction modification system DNA 
methyltransferase subunit HsdM 
930322 930909 + 195 
type I restriction modification system DNA 
specificity subunit HsdS 
930830 931465 - 211 
type I restriction modification system DNA 
specificity subunit HsdS 
931508 932482 + 324 integrase 
a
Coordinates are based on the nucleotide sequence of JCM 1112 (GenBank NC_01609.1). 
  
Supplementary Table S2b. Prophage Lreu2 Gene Annotationsa  
New Annotation Coordinates 
Gene Start Gene Stop Strand Protein 
(aa) 
Protein Function Prediction 
1239954 1241084 + 376 phage integrase 
1239634 1239951 + 105 Lactobacillus conserved hypothetical protein 
1238962 1239471 + 169 conserved hypothetical protein 
1238393 1238833 + 146 conserved hypothetical protein 
1237943 1238380 + 145 phage repressor 
1237561 1237764 - 67 phage repressor 
1236739 1237512 - 257 phage antirepressor 
1236449 1236727 - 92 Lactobacillus conserved hypothetical protein 
1236326 1236448 - 40 hypothetical protein 
1236183 1236314 - 43 hypothetical protein 
1235663 1236169 + 168 hypothetical protein 
1235425 1235610 - 61 hypothetical protein 
1235159 1235389 - 76 hypothetical protein 
1234177 1235166 - 329 phage RecT family recombinase 
1233369 1234193 - 274 conserved hypothetical protein 
1232507 1233364 - 285 phage replication protein 
1232185 1232514 - 109 hypothetical protein 
1231817 1232188 - 123 hypothetical protein 
1231728 1231820 - 30 hypothetical protein 
1231463 1231741 - 92 hypothetical protein 
1231278 1231466 - 62 hypothetical protein 
1231126 1231278 - 50 hypothetical protein 
1230888 1231082 - 64 hypothetical protein 
1230628 1230888 - 86 hypothetical protein 
1230287 1230628 - 113 hypothetical protein 
1230099 1230287 - 62 hypothetical protein 
1229831 1230091 - 86 hypothetical protein 
1229520 1229831 - 103 hypothetical protein 
1229314 1229457 - 47 hypothetical protein 
1228810 1229232 - 140 Lactobacillus conserved hypothetical protein 
1228513 1228797 - 94 hypothetical protein 
1227062 1227904 - 280 hypothetical protein 
1226331 1226789 - 152 IS200 family transposase  
1226026 1226172 - 48 Lactobacillus conserved hypothetical protein 
1225492 1225671 - 59 Lactobacillus conserved hypothetical protein 
1224888 1225424 - 178 phage endonuclease 
1224270 1224746 - 158 phage terminase small subunit protein 
1223810 1224247 + 145 hypothetical protein 
1223640 1223813 + 57 hypothetical protein 
1221685 1223574 - 629 phage terminase large subunit protein 
1220308 1221498 - 396 phage portal protein 
1219590 1220321 - 243 S14 family ClpP protease 
New Annotation Coordinates 
Gene Start Gene Stop Strand Protein 
(aa) 
Protein Function Prediction 
1218425 1219600 - 391 phage major capsid protein 
1218037 1218405 - 122 phage DNA packaging protein 
1217718 1218068 - 116 phage head-tail joining/adaptor protein 
1217300 1217716 - 138 phage head-tail joining protein 
1216920 1217303 - 127 phage tail protein 
1216205 1216915 - 236 phage tail protein 
1215757 1216143 - 128 Lactobacillus conserved hypothetical protein 
1215533 1215682 - 49 hypothetical protein 
1211701 1215531 - 1276 phage tail tape measure protein 
1210841 1211686 - 281 phage tail protein 
1209082 1210827 - 581 glycoside hydrolase/peptidase/lysin 
1205055 1209134 - 1359 hypothetical protein 
1204820 1205062 - 80 hypothetical protein 
1204508 1204777 - 89 
conserved hypothetical Lactobacillus phage 
protein 
1203350 1204495 - 381 
conserved hypothetical Lactobacillus phage 
protein 
1202238 1203347 - 369 
conserved hypothetical Lactobacillus phage 
protein 
1201822 1202226 - 134 hypothetical protein 
1201710 1201829 - 39 hypothetical protein 
1201120 1201671 - 183 hypothetical protein 
1199993 1201081 - 362 hypothetical protein 
1199652 1199978 - 108 hypothetical protein 
1199284 1199655 - 123 hypothetical protein 
1198095 1199294 - 399 N-acetylmuramoyl-L-alanine amidase 
1197209 1197328 + 39 hypothetical protein 
1196399 1196857 - 152 IS200 family transposase  
a
Coordinates are based on the nucleotide sequence of JCM 1112 (GenBank NC_01609.1).  
  
Supplementary Table S2c. Prophage Lreu3 Gene Annotationsa 
New Annotation Coordinates 
Gene Start Gene Stop Strand Protein 
(aa) 
Protein Function Prediction 
462928 463611 + 227 integrase 
463616 464374 + 252 ISChy4 transposase 
464301 464597 - 98 hypothetical protein HMPREF0538_20464 
464600 465334 - 244 
type II restriction-modification system 
modification subunit 
465378 465590 - 70 hypothetical protein HMPREF0538_20466 
465619 468228 - 869 hypothetical protein HMPREF0538_20467 
468234 469532 - 432 hypothetical protein HMPREF0538_20468 
469910 470368 + 152 hypothetical protein HMPREF0538_20469 
470451 470654 + 67 hypothetical protein HMPREF0538_20470 
470638 470955 + 105 hypothetical protein HMPREF0538_20471 
470952 472091 + 379 Lactobacillus conserved phage protein 
472069 472644 + 191 phage-associated protein 
472700 474634 + 644 DNA polymerase 
474701 475105 + 134 hypothetical protein HMPREF0538_20475 
475108 477363 + 751 P4 family phage protein 
477411 477857 + 148 VRR-NUC domain protein 
477838 479193 + 451 SNF2 domain protein 
479190 479657 + 155 probable restriction endonuclease 
479806 480183 + 125 HNH endonuclease domain protein 
480303 480845 + 180 hypothetical protein HMPREF0538_20481 
480845 482071 + 408 DNA (cytosine-5-)-methyltransferase 
482144 482764 + 206 hypothetical protein HMPREF0538_20483 
482767 482973 + 68 hypothetical protein HMPREF0538_20484 
483104 484072 + 322 transposase 
484096 485715 + 539 prophage protein 
485744 487009 + 421 HK97 family portal protein 
487006 487677 + 223 S14 family peptidase ClpP 
487696 488874 + 392 HK97 family phage protein 
488891 489169 + 92 hypothetical protein HMPREF0538_20490 
489169 489552 + 127 bacteriophage head-tail adaptor 
489539 489952 + 137 holin 
489949 490098 + 49 hypothetical protein HMPREF0538_20493 
490120 490239 + 39 hypothetical protein HMPREF0538_20494 
490306 490827 + 173 lysozyme 
491094 491327 + 77 hypothetical protein HMPREF0538_20496 
491363 493024 + 553 integrase/recombinase 
493017 494594 + 525 Integrase/recombinase 
494764 495615 + 283 ABC transporter ATP-binding protein 
495578 496468 + 296 ABC transporter 
496471 496923 + 150 LytR/AlgR family transcriptional regulator 
496925 497311 + 128 hypothetical protein HMPREF0538_20502 
New Annotation Coordinates 
Gene Start Gene Stop Strand Protein 
(aa) 
Protein Function Prediction 
497439 497561 - 40 hypothetical protein HMPREF0538_20503 
497928 498164 - 78 hypothetical protein HMPREF0538_20504 
498189 501305 - 1038 type I site-specific deoxyribonuclease 
501360 502517 - 385 
type I restriction/modification specificity 
protein 
502514 503482 - 322 integrase/recombinase 
503550 504209 + 219 
type I restriction-modification system 
specificity subunit 
504206 504736 - 176 hypothetical protein HMPREF0538_20509 
504726 506264 - 512 
type I restriction-modification system DNA-
methyltransferase 
506261 506482 - 73 hypothetical protein HMPREF0538_20511 
506494 509106 - 870 hypothetical protein HMPREF0538_20512 
509111 510496 - 461 hypothetical protein HMPREF0538_20513 
510807 511325 + 172 sigma-70 family protein 
511407 511628 + 73 hypothetical protein HMPREF0538_20515 
511612 511947 + 111 hypothetical protein HMPREF0538_20516 
511944 513080 + 378 phage protein 
513061 513636 + 191 hypothetical protein HMPREF0538_20518 
513692 515626 + 644 DNA-directed DNA polymerase 
515713 516099 + 128 hypothetical protein HMPREF0538_20520 
516102 518357 + 751 P4 family prophage protein 
518405 518851 + 148 VRR-NUC domain protein 
518832 520187 + 451 SNF2 domain protein 
520184 520651 + 155 probable restriction endonuclease 
520799 521176 + 125 HNH endonuclease domain protein 
521299 521841 + 180 hypothetical protein HMPREF0538_20526 
521841 523070 + 409 DNA (cytosine-5-)-methyltransferase 
523144 523776 + 210 hypothetical protein HMPREF0538_20528 
523769 523975 + 68 hypothetical protein HMPREF0538_20529 
524041 525642 + 533 prophage protein 
525670 525831 + 53 hypothetical protein HMPREF0538_20531 
525972 526133 - 53 lipoprotein 
526190 527446 + 418 HK97 family portal protein 
527443 528105 + 220 S14 family peptidase ClpP 
528126 529304 + 392 HK97 family major capsid protein 
529317 529595 + 92 hypothetical protein HMPREF0538_20536 
529596 529976 + 126 bacteriophage head-tail adaptor 
529966 530388 + 140 holin 
530486 530674 + 62 hypothetical protein HMPREF0538_20539 
530736 532289 + 517 phage integrase/recombinase 
532276 532680 + 134 phage integrase/recombinase 
532667 534253 + 528 phage integrase/recombinase 
a
Coordinates are based on the nucleotide sequence of ATCC 55730 (GenBank NC_015697).  
Supplementary Table S2d. Prophage Lreu4 Gene Annotationsa 
New Annotation Coordinates 
Gene Start Gene Stop Strand Protein 
(aa) 
Protein Function Prediction 
2099733 2099939 + 68 hypothetical protein HMPREF0538_22063 
2099951 2100718 + 255 phage antirepressor 
2100730 2100858 + 42 hypothetical protein HMPREF0538_22065 
2100858 2100980 + 40 hypothetical protein HMPREF0538_22066 
2100995 2101201 + 68 DNA-binding protein 
2101198 2101377 + 59 hypothetical protein HMPREF0538_22068 
2101413 2101643 + 76 hypothetical protein HMPREF0538_22069 
2101636 2101908 + 90 6-phospho-beta-glucosidase 
2101912 2102664 + 250 Erf family protein 
2102667 2103347 + 226 hypothetical protein HMPREF0538_22072 
2103337 2103765 + 142 single-strand binding protein 
2103778 2104608 + 276 phage protein 
2104624 2105421 + 265 DNA replication protein 
2105424 2105576 + 50 chaperone DnaJ 
2105580 2105840 + 86 hypothetical protein HMPREF0538_22077 
2105830 2106351 + 173 hypothetical protein HMPREF0538_22078 
2106364 2106921 + 185 hypothetical protein HMPREF0538_22079 
2106998 2107447 + 149 hypothetical protein HMPREF0538_22080 
2107440 2107718 + 92 hypothetical protein HMPREF0538_22081 
2107715 2108086 + 123 
oxygen-independent coproporphyrinogen III 
oxidase 
2108101 2109231 - 376 IS30 family transposase 
2109293 2109490 + 65 XRE family transcriptional regulator 
2109480 2109722 + 80 hypothetical protein HMPREF0538_22085 
2109691 2110077 + 128 hypothetical protein HMPREF0538_22086 
2110190 2110384 + 64 hypothetical protein HMPREF0538_22087 
2110488 2110631 + 47 hypothetical protein HMPREF0538_22088 
2110663 2110854 + 63 hypothetical protein HMPREF0538_22089 
2110964 2111479 + 171 hypothetical protein HMPREF0538_22090 
2112304 2112783 + 159 XRE family transcriptional regulator 
2112773 2113207 + 144 hypothetical protein HMPREF0538_22092 
2113753 2113932 + 59 probable phage-associated protein 
2113925 2114203 + 92 hypothetical protein HMPREF0538_22094 
2114447 2114617 + 56 hypothetical protein HMPREF0538_22095 
2114643 2114882 - 79 hypothetical protein HMPREF0538_22096 
2114838 2115695 + 285 HNH endonuclease domain protein 
2115879 2116346 + 155 phage terminase small subunit 
2116343 2118052 + 569 phage terminase large subunit 
2118033 2118395 + 120 hypothetical protein HMPREF0538_22100 
2118558 2119817 + 419 phage portal protein 
2119756 2120409 + 217 phage head maturation protease 
2120410 2121546 + 378 phage protein 
New Annotation Coordinates 
Gene Start Gene Stop Strand Protein 
(aa) 
Protein Function Prediction 
2121688 2122101 + 137 phage protein 
2122004 2122357 + 117 hypothetical protein HMPREF0538_22105 
2122341 2122715 + 124 phage protein 
2122712 2123131 + 139 phage protein 
2123131 2123760 + 209 phage major tail protein 
2123813 2124154 + 113 glutamyl-tRNA synthetase 
2124163 2124333 + 56 hypothetical protein HMPREF0538_22110 
2124350 2128852 + 1500 
TP901 family phage tail tape measure 
protein 
2128856 2129698 + 280 hypothetical protein HMPREF0538_22112 
2129773 2132241 + 822 phage lysin 
2132254 2132616 + 120 hypothetical protein HMPREF0538_22114 
2132616 2134490 + 624 phage minor head protein 
2134502 2135287 + 261 hypothetical protein HMPREF0538_22116 
2135302 2135700 + 132 hypothetical protein HMPREF0538_22117 
2135944 2136324 + 126 hypothetical protein HMPREF0538_22118 
2136485 2136961 + 158 hypothetical protein HMPREF0538_22119 
2136974 2137900 + 308 endolysin 
2138047 2138205 + 52 hypothetical protein HMPREF0538_22121 
a
Coordinates are based on the nucleotide sequence of ATCC 55730 (GenBank NC_015697).  
Supplementary Table S3. Arginine Catabolism Gene Cluster Annotations
a
  
 
New Annotation Coordinates 
Gene 
Start 
Gene 
Stop 
Strand 
Protein 
(aa) 
Protein Function Prediction 
484793 485251 - 152 IS200 family transposase 
485472 486311 - 279 transcriptional regulator 
486564 487571 + 335 ornithine carbamoyltransferase ArcB 
487588 488520 + 310 carbamate kinase ArcC 
488564 489478 - 304 DMT drug/metabolite transporter 
489562 490143 - 193 M10 family zinc metallopeptidase  
490419 490787 + 122 probable secreted cupredoxin domain protein 
490787 491074 + 95 probable cupredoxin domain protein 
491074 493011 + 645 P-type ATPase superfamily copper transporter 
493130 493606 + 158 Lactobacillus conserved hypothetical protein 
493835 494164 - 109 Lactobacillus conserved hypothetical protein 
494395 495783 + 462 CPA1 family monovalent Na+/H+ antiporter 
496429 496611 - 60 conserved hypothetical protein 
496613 496789 - 58 hypothetical protein 
497061 497399 - 112 transposase 
497426 498307 - 293 transposase 
499483 499848 - 121 hypothetical protein 
499845 499976 - 43 hypothetical protein 
500400 500801 - 133 Lactobacillus conserved hypothetical protein 
500818 501219 - 133 hypothetical protein 
501268 502227 - 319 hypothetical protein 
502244 502468 - 74 hypothetical protein 
502468 502938 - 156 hypothetical protein 
503095 503859 - 254 possible ribonuclease H 
503856 504455 - 199 conserved hypothetical protein 
504681 505274 - 197 hypothetical protein 
505465 506484 + 339 beta-lactamase/penicillin binding protein 
506692 507924 + 410 arginine deiminase ArcA 
508035 508496 + 153 ArgR family transcriptional regulator 
508517 509938 + 473 APC family amino acid polyamine organocation transporter 
509996 511393 + 466 APC family amino acid polyamine organocation transporter 
a
Coordinates are based on the nucleotide sequence of JCM 1112 (GenBank NC_01609.1). 
Supplementary Table S4. Folate biosynthesis gene annotations
* 
Gene Protein Function Prediction Strand 
Protein 
(aa) 
ATCC 55730
a 
JCM 1112
b 
Start Stop Start Stop 
folC1 folypolyglutamate synthase + 437 1764152 1765465 578388 579701 
folA dihydrofolate reductase + 162 2068933 2069421 853517 854005 
folP dihydropteroate synthase - 387 277203 278366 1364163 1364975 
folQ 
dihydroneopterin triphosphate 
diphosphatase 
- 195 278368 278955 1365328 1365915 
thfS 
(folC2) 
tetrahydrofolate synthase - 419 278945 280204 1365905 1367164 
folE GTP cyclohydrolase I - 192 280191 280769 1367151 1367729 
folK 
2-amino-4-hydroxy-6-
hydroxymethyldihydropteridine 
diphosphokinase 
- 170 280751 281263 1367711 1368223 
folB dihydroneopterin aldolase - 111 281266 281601 1368226 1368561 
*
Coordinates are based on the nucleotide sequence of 
a
ATCC 55730 (GenBank NC_015697) and 
b
JCM 1112 (GenBank NC_01609.1).  
 
 
Supplementary Table S5a. Clade VI pdu-cbi-hem-cob gene cluster annotations
a
 
Start Stop Strand Protein 
(aa) 
Gene Protein Function Prediction 
919827 920534 - 235 pduF MIP family glycerol uptake facilitator protein 
918921 919754 - 277 eutJ ethanolamine utilization protein 
917746 918840 + 364 pocR AraC-family transcriptional regulator 
917212 917490 - 92 pduA carbon dioxide concentrating mechanisms, 
carboxysome shell protein 
916398 917114 - 238 pduB propanediol utilization protein 
914697 916373 - 558 pduC glycerol dehydratase, large subunit 
913969 914679 - 236 pduD glycerol dehydratase, medium subunit 
913440 913955 - 171 pduE glycerol dehydratase, small subunit 
911565 913412 - 615 pduG propanediol dehydratase reactivation protein 
911219 911599 - 126 pduH propanediol dehydratase reactivation protein 
910642 911211 - 189 pduK propanediol utilization protein 
910342 910629 - 95 pduJ carbon dioxide concentrating mechanisms, 
carboxysome shell protein 
909675 910319 - 214 pduL propanediol utilization protein 
909141 909644 - 167 pduM propanediol utilization protein 
908881 909153 - 90 pduN carbon dioxide concentrating mechanisms, 
carboxysome shell protein 
908273 908860 - 195 pduO propanediol utilization protein 
907797 908270 - 157 pduObis propanediol utilization protein 
906367 907794 - 475 pduP CoA-dependent propionaldehyde 
dehydrogenase 
905228 906367 - 379 pduQ propanediol dehydrogenase 
904017 905204 - 395 pduW acetate kinase 
903654 904001 - 115 pduU propanediol utilization protein 
902794 903588 - 264  conserved hypothetical protein 
902014 902646 - 210  phosphoglycerate mutase 
901457 902017 - 186  hypothetical protein 
901036 901464 + 142 pduV propanediol utilization protein 
900479 900928 - 149  flavodoxin 
899616 900464 - 282  flavoprotein 
898973 899557 + 194  putative ATP:cob(I)alamin 
adenosyltransferase 
897545 898633 - 362 cobD L-threonine-O-3-phosphate decarboxylase 
896184 897548 - 454 cbiA cobyrinic acid A, C-diamide synthase 
895228 896187 - 319 cbiB cobalamin biosynthesis protein 
894536 895222 - 228 cbiC precorrin-8X methylmutase 
893407 894564 - 385 cbiD cobalamin biosynthesis protein 
892811 893416 - 201 cbiE precorrin-6Y C5,15-methyltransferase 
Start Stop Strand Protein 
(aa) 
Gene Protein Function Prediction 
892264 892818 - 184 cbiT precorrin-8W decarboxylase 
891488 892258 - 256 cbiF precorrin-4 C11-methyltransferase 
890430 891485 - 351 cbiG cobalamin biosynthesis protein 
889693 890418 - 241 cbiH precorrin-3B C17-methyltransferase 
888938 889696 - 252 cbiJ precorrin-6X reductase 
887554 888948 - 464 cobA uroporphyrinogen-III C-methyltransferase 
886785 887561 - 258 cbiK cobalt chelatase 
886081 886779 - 232 cbiL precorrin-2 C20-methyltransferase 
885335 886078 - 247 cbiM cobalamin biosynthesis protein 
885015 885338 - 107 cbiN cobalt ABC transporter permease component 
884312 884989 - 225 cbiQ cobalt ABC transporter permease component 
883493 884302 - 269 cbiO cobalt ABC transporter ATP-binding protein 
881886 883403 - 505 cbiP adenosylcobyric acid synthase 
881419 881889 - 156 cysG putative siroheme synthase  
880151 881416 - 421 hemA glutamyl-tRNA reductase 
879244 880161 - 305 hemC porphobilinogen deaminase 
878267 879238 - 323 hemB delta-aminolevulinic acid dehydratase 
876952 878283 - 443 hemL glutamate-1-semialdehyde 2,1-
aminotransferase 
876300 876890 - 196 cobU adenosylocobinamide-phosphate 
guanylyltransferase 
875530 876291 - 253 cobS cobalamin-5’-phosphate synthase 
874943 875533 - 196 cobC alpha-ribazole-5’-phosphate phosphatase 
874219 874929 - 236  type I site-specific deoxyribonuclease 
873165 874217 - 350 cobT nicotinate-nucleotide-dimethylbenzimidazole 
phosphoribosyltransferase 
a
Coordinates are based on the nucleotide sequence of ATCC 55730 (GenBank NC_015697). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table S5b. Clade II pdu-cbi-hem-cob gene cluster annotations
a
 
Start Stop Strand Protein 
(aa) 
Gene Protein Function Prediction 
1844734 1845441 - 235 pduF MIP family glycerol uptake facilitator 
protein 
1843816 1844649 - 277 eutJ ethanolamine utilization protein 
1842696 1843775 + 359 pocR AraC-family transcriptional regulator 
1842161 1842442 - 93 pduA carbon dioxide concentrating mechanisms, 
carboxysome shell protein 
1841347 1842063 - 238 pduB propanediol utilization protein 
1839646 1841322 - 558 pduC glycerol dehydratase, large subunit 
1838918 1839628 - 236 pduD glycerol dehydratase, medium subunit 
1838390 1838905 - 171 pduE glycerol dehydratase, small subunit 
1836509 1838359 - 616 pduG propanediol dehydratase reactivation 
protein 
1836163 1836546 - 127 pduH propanediol dehydratase reactivation 
protein 
1835586 1836155 - 189 pduK propanediol utilization protein 
1835283 1835573 - 96 pduJ carbon dioxide concentrating mechanisms, 
carboxysome shell protein 
1834610 1835254 - 214 pduL propanediol utilization protein 
1834075 1834578 - 167 pduM propanediol utilization protein 
1833815 1834093 - 92 pduN carbon dioxide concentrating mechanisms, 
carboxysome shell protein 
1833207 1833794 - 195 pduO propanediol utilization protein 
1832731 1833204 - 157 pduObis propanediol utilization protein 
1831295 1832728 - 477 pduP CoA-dependent propionaldehyde 
dehydrogenase 
1830156 1831277 - 373 pduQ propanediol dehydrogenase 
1828948 1830132 - 394 pduW acetate kinase 
1828585 1828932 - 115 pduU propanediol utilization protein 
1827718 1828512 - 264  conserved hypothetical protein 
1826977 1827621 - 214  phosphoglycerate mutase 
1826423 1826980 - 185  hypothetical protein 
1826002 1826430 + 142 pduV propanediol utilization protein 
1825446 1825895 - 149  flavodoxin 
1824582 1825424 - 280  flavoprotein 
1823968 1824534 + 188  putative ATP:cob(I)alamin 
adenosyltransferase 
1822871 1823839 - 322  transposase 
1821438 1822526 - 362 cobD L-threonine-O-3-phosphate decarboxylase 
1820074 1821438 - 454 cbiA cobyrinic acid A, C-diamide synthase 
1819118 1820077 - 319 cbiB cobalamin biosynthesis protein 
Start Stop Strand Protein 
(aa) 
Gene Protein Function Prediction 
1818429 1819112 - 227 cbiC precorrin-8X methylmutase 
1817297 1818448 - 383 cbiD cobalamin biosynthesis protein 
1816698 1817300 - 200 cbiE precorrin-6Y C5,15-methyltransferase 
1816151 1816705 - 184 cbiT precorrin-8W decarboxylase 
1815373 1816134 - 253 cbiF precorrin-4 C11-methyltransferase 
1814315 1815370 - 351 cbiG cobalamin biosynthesis protein 
1813577 1814302 - 241 cbiH precorrin-3B C17-methyltransferase 
1812822 1813580 - 252 cbiJ precorrin-6X reductase 
1811438 1812832 - 464 cobA uroporphyrinogen-III C-methyltransferase 
1810666 1811445 - 259 cbiK cobalt chelatase 
1809951 1810664 - 237 cbiL precorrin-2 C20-methyltransferase 
1809221 1809967 - 248 cbiM cobalamin biosynthesis protein 
1808913 1809224 - 103 cbiN cobalt ABC transporter permease 
component 
1808215 1808892 - 225 cbiQ cobalt ABC transporter permease 
component 
1807400 1808203 - 267 cbiO cobalt ABC transporter ATP-binding 
protein 
1805820 1807325 - 501 cbiP adenosylcobyric acid synthase 
1805347 1805805 - 152 cysG putative siroheme synthase  
1804080 1805345 - 421 hemA glutamyl-tRNA reductase 
1803173 1804090 - 305 hemC porphobilinogen deaminase 
1802196 1803167 - 323 hemB delta-aminolevulinic acid dehydratase 
1800881 1802176 - 431 hemL glutamate-1-semialdehyde 2,1-
aminotransferase 
1800228 1800818 - 196 cobU adenosylocobinamide-phosphate 
guanylyltransferase 
1799458 1800219 - 253 cobS cobalamin-5’-phosphate synthase 
1798871 1799461 - 196 cobC alpha-ribazole-5’-phosphate phosphatase 
1798124 1798834 - 236  type I site-specific deoxyribonuclease 
1797070 1798140 - 356 cobT nicotinate-nucleotide-
dimethylbenzimidazole 
phosphoribosyltransferase 
a
Coordinates are based on the nucleotide sequence of JCM 1112 (GenBank NC_01609.1). 
 
Supplementary Table S8. L. reuteri Clade II Histidine Decarboxylase Gene Cluster
a
 
Start Stop Strand 
Protein 
(aa) 
Gene Protein Function Prediction 
1927408 1928862 - 484 hdcP APC family amino acid-polyamine-
organocation transporter 
1926216 1927151 - 311 hdcA histidine decarboxylase 
1925451 1925975 - 174 hdcB conserved hypothetical protein HdcB 
1923821 1925122 - 433 hisRS2 histidyl-tRNA synthase 
a
Coordinates are based on the nucleotide sequence of JCM1112 (GenBank NC_010609). 
 
 
 
